Concepts (311)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Papio | 22 | 2025 | 81 | 1.840 |
Why?
|
| Zika Virus | 5 | 2022 | 28 | 1.680 |
Why?
|
| Zika Virus Infection | 5 | 2022 | 28 | 1.670 |
Why?
|
| Monkey Diseases | 6 | 2020 | 16 | 1.420 |
Why?
|
| Antibodies, Viral | 10 | 2023 | 80 | 1.360 |
Why?
|
| Viremia | 4 | 2019 | 16 | 1.270 |
Why?
|
| Whooping Cough | 8 | 2023 | 15 | 1.140 |
Why?
|
| Papio anubis | 8 | 2025 | 48 | 0.890 |
Why?
|
| West Nile virus | 4 | 2010 | 20 | 0.840 |
Why?
|
| Semen | 2 | 2020 | 29 | 0.780 |
Why?
|
| Animals | 41 | 2025 | 10580 | 0.760 |
Why?
|
| Respiratory Syncytial Virus Infections | 3 | 2021 | 15 | 0.720 |
Why?
|
| Disease Models, Animal | 11 | 2021 | 1494 | 0.700 |
Why?
|
| Bordetella pertussis | 7 | 2023 | 8 | 0.660 |
Why?
|
| Retroviridae Infections | 1 | 2019 | 1 | 0.640 |
Why?
|
| Testis | 1 | 2019 | 39 | 0.630 |
Why?
|
| Spermatozoa | 1 | 2019 | 34 | 0.620 |
Why?
|
| RNA, Viral | 4 | 2020 | 68 | 0.570 |
Why?
|
| Schistosomiasis | 3 | 2025 | 10 | 0.540 |
Why?
|
| Blood Component Removal | 1 | 2017 | 4 | 0.540 |
Why?
|
| Cell Lineage | 1 | 2017 | 51 | 0.530 |
Why?
|
| Vaccines | 3 | 2025 | 35 | 0.530 |
Why?
|
| Dyslipidemias | 1 | 2017 | 32 | 0.520 |
Why?
|
| West Nile Fever | 4 | 2010 | 15 | 0.510 |
Why?
|
| Lipoproteins | 1 | 2017 | 99 | 0.510 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2017 | 111 | 0.500 |
Why?
|
| Glycoproteins | 2 | 2019 | 123 | 0.490 |
Why?
|
| Viral Proteins | 4 | 2023 | 63 | 0.450 |
Why?
|
| Cell Differentiation | 1 | 2017 | 419 | 0.440 |
Why?
|
| Pertussis Vaccine | 4 | 2023 | 6 | 0.440 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 3 | 2021 | 9 | 0.440 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2005 | 328 | 0.430 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2013 | 3 | 0.400 |
Why?
|
| Immunoglobulin G | 6 | 2022 | 272 | 0.380 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2022 | 47 | 0.380 |
Why?
|
| Viral Vaccines | 2 | 2011 | 14 | 0.370 |
Why?
|
| Rift Valley Fever | 1 | 2011 | 1 | 0.360 |
Why?
|
| Rift Valley fever virus | 1 | 2011 | 1 | 0.360 |
Why?
|
| Vaccinia virus | 1 | 2011 | 6 | 0.360 |
Why?
|
| Virus Replication | 4 | 2025 | 66 | 0.350 |
Why?
|
| Polymerase Chain Reaction | 3 | 2010 | 270 | 0.350 |
Why?
|
| Endothelial Cells | 3 | 2025 | 361 | 0.350 |
Why?
|
| Immunity, Innate | 2 | 2025 | 231 | 0.340 |
Why?
|
| Virology | 1 | 2010 | 4 | 0.330 |
Why?
|
| Inflammation Mediators | 2 | 2025 | 166 | 0.330 |
Why?
|
| Genome, Viral | 1 | 2010 | 34 | 0.330 |
Why?
|
| Humans | 25 | 2025 | 28581 | 0.300 |
Why?
|
| Antibodies, Bacterial | 5 | 2023 | 103 | 0.290 |
Why?
|
| Pertussis Toxin | 2 | 2020 | 7 | 0.280 |
Why?
|
| Antibodies, Neutralizing | 4 | 2021 | 73 | 0.280 |
Why?
|
| Male | 13 | 2025 | 13771 | 0.280 |
Why?
|
| Antiviral Agents | 3 | 2025 | 114 | 0.270 |
Why?
|
| Female | 17 | 2025 | 15471 | 0.270 |
Why?
|
| Schistosoma mansoni | 4 | 2020 | 12 | 0.260 |
Why?
|
| Antibodies, Helminth | 3 | 2025 | 10 | 0.260 |
Why?
|
| Antigens, Helminth | 3 | 2025 | 11 | 0.260 |
Why?
|
| Vaccination | 5 | 2021 | 192 | 0.250 |
Why?
|
| Transcription, Genetic | 4 | 2018 | 404 | 0.250 |
Why?
|
| DNA, Viral | 2 | 2008 | 63 | 0.240 |
Why?
|
| Lung | 3 | 2023 | 380 | 0.240 |
Why?
|
| Methylene Blue | 1 | 2005 | 8 | 0.240 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2025 | 28 | 0.230 |
Why?
|
| Herpesviridae | 1 | 2005 | 3 | 0.230 |
Why?
|
| Tetraspanins | 1 | 2025 | 54 | 0.230 |
Why?
|
| Capillary Permeability | 1 | 2025 | 53 | 0.230 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2025 | 65 | 0.230 |
Why?
|
| Diet, Western | 1 | 2025 | 44 | 0.230 |
Why?
|
| Receptors, Steroid | 1 | 2025 | 26 | 0.230 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2025 | 64 | 0.220 |
Why?
|
| Inflammation | 3 | 2025 | 641 | 0.220 |
Why?
|
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 21 | 0.220 |
Why?
|
| Respiratory Syncytial Virus, Human | 2 | 2021 | 12 | 0.220 |
Why?
|
| Organic Chemicals | 1 | 2004 | 14 | 0.220 |
Why?
|
| gamma-Globulins | 1 | 2023 | 3 | 0.210 |
Why?
|
| Squalene | 1 | 2023 | 3 | 0.210 |
Why?
|
| Melphalan | 1 | 2023 | 7 | 0.210 |
Why?
|
| Polysorbates | 1 | 2023 | 6 | 0.210 |
Why?
|
| Acetylglucosamine | 1 | 2023 | 17 | 0.210 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2025 | 126 | 0.210 |
Why?
|
| Intestinal Mucosa | 1 | 2025 | 197 | 0.210 |
Why?
|
| Cholesterol | 1 | 2025 | 202 | 0.210 |
Why?
|
| Respiratory Tract Infections | 1 | 2023 | 37 | 0.210 |
Why?
|
| Cell Membrane | 1 | 2025 | 259 | 0.210 |
Why?
|
| Fluorescent Dyes | 1 | 2004 | 92 | 0.210 |
Why?
|
| Influenza Vaccines | 1 | 2023 | 51 | 0.200 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2025 | 103 | 0.200 |
Why?
|
| Mice | 10 | 2023 | 4732 | 0.200 |
Why?
|
| Mucous Membrane | 2 | 2023 | 28 | 0.200 |
Why?
|
| Biomarkers | 3 | 2025 | 770 | 0.200 |
Why?
|
| Coinfection | 2 | 2020 | 14 | 0.190 |
Why?
|
| Schistosomiasis mansoni | 2 | 2020 | 7 | 0.190 |
Why?
|
| Pregnancy | 6 | 2025 | 1219 | 0.180 |
Why?
|
| Capillaries | 1 | 2021 | 33 | 0.180 |
Why?
|
| Lymphatic Vessels | 1 | 2021 | 22 | 0.180 |
Why?
|
| Lectins, C-Type | 1 | 2021 | 43 | 0.180 |
Why?
|
| Bronchi | 1 | 2021 | 38 | 0.180 |
Why?
|
| Liver | 2 | 2021 | 456 | 0.170 |
Why?
|
| Cell Adhesion Molecules | 1 | 2021 | 69 | 0.170 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 114 | 0.170 |
Why?
|
| Respiratory Mucosa | 1 | 2021 | 60 | 0.170 |
Why?
|
| Helminthiasis, Animal | 1 | 2020 | 3 | 0.170 |
Why?
|
| Immunization, Passive | 1 | 2020 | 20 | 0.170 |
Why?
|
| Cells, Cultured | 3 | 2021 | 1009 | 0.160 |
Why?
|
| Trichuriasis | 1 | 2020 | 5 | 0.160 |
Why?
|
| Liver Diseases, Parasitic | 1 | 2020 | 3 | 0.160 |
Why?
|
| Immunoglobulin M | 2 | 2018 | 28 | 0.160 |
Why?
|
| Vagina | 1 | 2020 | 42 | 0.160 |
Why?
|
| Blood-Testis Barrier | 1 | 2019 | 3 | 0.160 |
Why?
|
| Betaretrovirus | 1 | 2019 | 1 | 0.160 |
Why?
|
| Viral Fusion Proteins | 1 | 2019 | 2 | 0.160 |
Why?
|
| Spermatogenesis | 1 | 2019 | 11 | 0.160 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 38 | 0.160 |
Why?
|
| Immunity, Humoral | 1 | 2019 | 47 | 0.160 |
Why?
|
| DNA Primers | 3 | 2010 | 147 | 0.150 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2019 | 82 | 0.150 |
Why?
|
| Pilot Projects | 2 | 2020 | 458 | 0.150 |
Why?
|
| Cytokines | 2 | 2021 | 448 | 0.150 |
Why?
|
| Herpesvirus 8, Human | 3 | 2004 | 12 | 0.150 |
Why?
|
| Stem Cells | 1 | 2019 | 122 | 0.150 |
Why?
|
| Protozoan Vaccines | 1 | 2018 | 5 | 0.150 |
Why?
|
| Brazil | 1 | 2018 | 24 | 0.150 |
Why?
|
| Praziquantel | 1 | 2018 | 2 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 247 | 0.150 |
Why?
|
| Vero Cells | 2 | 2011 | 12 | 0.140 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2018 | 4 | 0.140 |
Why?
|
| Hyperventilation | 1 | 2017 | 3 | 0.140 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 136 | 0.140 |
Why?
|
| Ape Diseases | 1 | 2017 | 4 | 0.140 |
Why?
|
| Apnea | 1 | 2017 | 13 | 0.140 |
Why?
|
| False Negative Reactions | 2 | 2010 | 24 | 0.140 |
Why?
|
| Respiratory Function Tests | 1 | 2017 | 27 | 0.140 |
Why?
|
| Propofol | 1 | 2017 | 10 | 0.140 |
Why?
|
| Anesthetics, Intravenous | 1 | 2017 | 15 | 0.140 |
Why?
|
| Infant | 3 | 2021 | 1019 | 0.130 |
Why?
|
| Phenotype | 2 | 2017 | 682 | 0.130 |
Why?
|
| Macrophages | 1 | 2019 | 302 | 0.130 |
Why?
|
| Bordetella bronchiseptica | 1 | 2016 | 4 | 0.130 |
Why?
|
| Bordetella Infections | 1 | 2016 | 4 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 3 | 2021 | 278 | 0.120 |
Why?
|
| Lymphocyte Activation | 1 | 2017 | 210 | 0.120 |
Why?
|
| Molecular Sequence Data | 4 | 2008 | 1056 | 0.120 |
Why?
|
| Base Sequence | 3 | 2008 | 588 | 0.120 |
Why?
|
| Case-Control Studies | 1 | 2017 | 732 | 0.120 |
Why?
|
| Parasite Egg Count | 3 | 2020 | 9 | 0.110 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2015 | 147 | 0.110 |
Why?
|
| Papio cynocephalus | 2 | 2011 | 5 | 0.110 |
Why?
|
| Treatment Outcome | 2 | 2018 | 2402 | 0.110 |
Why?
|
| Mice, SCID | 2 | 2011 | 60 | 0.100 |
Why?
|
| Shiga Toxins | 1 | 2013 | 1 | 0.100 |
Why?
|
| Enterohemorrhagic Escherichia coli | 1 | 2013 | 1 | 0.100 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2013 | 26 | 0.100 |
Why?
|
| Time Factors | 1 | 2017 | 1600 | 0.100 |
Why?
|
| Chemotaxis | 1 | 2013 | 28 | 0.100 |
Why?
|
| Species Specificity | 1 | 2013 | 193 | 0.100 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2013 | 81 | 0.090 |
Why?
|
| Vaccines, Synthetic | 1 | 2011 | 9 | 0.090 |
Why?
|
| Kidney | 1 | 2013 | 286 | 0.090 |
Why?
|
| Neutralization Tests | 3 | 2020 | 34 | 0.090 |
Why?
|
| HeLa Cells | 1 | 2011 | 208 | 0.090 |
Why?
|
| Adenylyl Cyclases | 1 | 2010 | 14 | 0.090 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2010 | 5 | 0.090 |
Why?
|
| Insulin-Secreting Cells | 1 | 2010 | 18 | 0.080 |
Why?
|
| Birds | 1 | 2010 | 25 | 0.080 |
Why?
|
| Cyclic AMP | 1 | 2010 | 87 | 0.080 |
Why?
|
| Fetus | 2 | 2022 | 79 | 0.080 |
Why?
|
| Epithelial Cells | 2 | 2023 | 256 | 0.080 |
Why?
|
| Placenta | 2 | 2022 | 78 | 0.080 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 166 | 0.080 |
Why?
|
| Glucose | 1 | 2010 | 207 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 376 | 0.070 |
Why?
|
| Simian virus 40 | 1 | 2008 | 8 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2020 | 273 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 453 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2025 | 1454 | 0.060 |
Why?
|
| Herpesviridae Infections | 2 | 2004 | 17 | 0.060 |
Why?
|
| West Nile Virus Vaccines | 1 | 2006 | 2 | 0.060 |
Why?
|
| Sarcoma, Kaposi | 2 | 2003 | 8 | 0.060 |
Why?
|
| Viral Plaque Assay | 1 | 2005 | 4 | 0.060 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2025 | 16 | 0.060 |
Why?
|
| Sterilization | 1 | 2005 | 8 | 0.060 |
Why?
|
| Africa | 1 | 2025 | 18 | 0.060 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2025 | 25 | 0.060 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2025 | 33 | 0.060 |
Why?
|
| Blood | 1 | 2005 | 34 | 0.060 |
Why?
|
| Simvastatin | 1 | 2025 | 24 | 0.060 |
Why?
|
| Animals, Newborn | 2 | 2017 | 181 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 257 | 0.060 |
Why?
|
| Encephalitis Virus, Eastern Equine | 1 | 2005 | 1 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2025 | 76 | 0.060 |
Why?
|
| Light | 1 | 2005 | 118 | 0.060 |
Why?
|
| Blood Transfusion | 1 | 2005 | 77 | 0.060 |
Why?
|
| Laminin | 1 | 2004 | 21 | 0.060 |
Why?
|
| Proteoglycans | 1 | 2004 | 38 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2004 | 50 | 0.050 |
Why?
|
| Lymphoma | 1 | 2004 | 26 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2025 | 128 | 0.050 |
Why?
|
| Benzothiazoles | 1 | 2004 | 5 | 0.050 |
Why?
|
| Diamines | 1 | 2004 | 6 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2004 | 27 | 0.050 |
Why?
|
| Quinolines | 1 | 2004 | 26 | 0.050 |
Why?
|
| Biopolymers | 1 | 2023 | 15 | 0.050 |
Why?
|
| Point Mutation | 1 | 2004 | 60 | 0.050 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2023 | 6 | 0.050 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2023 | 14 | 0.050 |
Why?
|
| Rhadinovirus | 1 | 2003 | 3 | 0.050 |
Why?
|
| Software | 1 | 2005 | 126 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2023 | 68 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2004 | 274 | 0.050 |
Why?
|
| Collagen | 1 | 2004 | 156 | 0.050 |
Why?
|
| Weight Loss | 1 | 2023 | 83 | 0.050 |
Why?
|
| Herpesvirus 2, Human | 1 | 2002 | 4 | 0.050 |
Why?
|
| Herpesvirus 1, Human | 1 | 2002 | 24 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2023 | 415 | 0.050 |
Why?
|
| Transgenes | 1 | 2002 | 63 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2025 | 861 | 0.050 |
Why?
|
| Interferon Type I | 1 | 2002 | 56 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2023 | 509 | 0.050 |
Why?
|
| Apoptosis | 1 | 2025 | 777 | 0.050 |
Why?
|
| Virus Internalization | 1 | 2021 | 12 | 0.040 |
Why?
|
| Cell Death | 1 | 2021 | 119 | 0.040 |
Why?
|
| Receptors, Chemokine | 1 | 2001 | 11 | 0.040 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2001 | 12 | 0.040 |
Why?
|
| Interferons | 1 | 2021 | 70 | 0.040 |
Why?
|
| Vaccines, Subunit | 1 | 2021 | 7 | 0.040 |
Why?
|
| Virus Latency | 1 | 2001 | 9 | 0.040 |
Why?
|
| Cellular Senescence | 1 | 2021 | 126 | 0.040 |
Why?
|
| Trichuris | 1 | 2020 | 5 | 0.040 |
Why?
|
| Animal Diseases | 1 | 2020 | 4 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2020 | 25 | 0.040 |
Why?
|
| Primates | 1 | 2020 | 22 | 0.040 |
Why?
|
| Granuloma | 1 | 2020 | 18 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2001 | 344 | 0.040 |
Why?
|
| Cell Line | 3 | 2010 | 698 | 0.040 |
Why?
|
| Microcephaly | 1 | 2019 | 8 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 285 | 0.040 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2019 | 13 | 0.040 |
Why?
|
| Fetal Death | 1 | 2019 | 21 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2001 | 249 | 0.040 |
Why?
|
| Histocytochemistry | 1 | 2018 | 20 | 0.040 |
Why?
|
| Fetal Diseases | 1 | 2019 | 18 | 0.040 |
Why?
|
| Antibodies, Protozoan | 1 | 2018 | 9 | 0.040 |
Why?
|
| Anthelmintics | 1 | 2018 | 4 | 0.040 |
Why?
|
| Trachea | 1 | 2018 | 34 | 0.040 |
Why?
|
| Mothers | 1 | 2019 | 124 | 0.040 |
Why?
|
| Transcriptome | 1 | 2020 | 214 | 0.040 |
Why?
|
| Bordetella parapertussis | 1 | 2018 | 1 | 0.040 |
Why?
|
| Bacterial Load | 1 | 2018 | 6 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 133 | 0.040 |
Why?
|
| Protozoan Proteins | 1 | 2018 | 54 | 0.040 |
Why?
|
| Vaccines, Attenuated | 1 | 2017 | 7 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 465 | 0.030 |
Why?
|
| Immunoglobulin A | 1 | 2017 | 23 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2018 | 421 | 0.030 |
Why?
|
| Adhesins, Bacterial | 1 | 2016 | 7 | 0.030 |
Why?
|
| Tumor Virus Infections | 2 | 2008 | 14 | 0.030 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2015 | 8 | 0.030 |
Why?
|
| Antigens, Bacterial | 1 | 2017 | 164 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2017 | 452 | 0.030 |
Why?
|
| Cricetulus | 1 | 2015 | 56 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 782 | 0.030 |
Why?
|
| CHO Cells | 1 | 2015 | 96 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 1601 | 0.030 |
Why?
|
| Child | 1 | 2021 | 2271 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2008 | 695 | 0.030 |
Why?
|
| Immunization Schedule | 1 | 2014 | 13 | 0.030 |
Why?
|
| Aging | 1 | 2021 | 979 | 0.030 |
Why?
|
| Disease Progression | 1 | 2015 | 475 | 0.030 |
Why?
|
| Prognosis | 1 | 2015 | 807 | 0.030 |
Why?
|
| Shiga Toxin 1 | 1 | 2013 | 1 | 0.030 |
Why?
|
| Shiga Toxin 2 | 1 | 2013 | 2 | 0.030 |
Why?
|
| Brain | 1 | 2019 | 753 | 0.030 |
Why?
|
| Eosinophils | 1 | 2013 | 6 | 0.030 |
Why?
|
| Mesangial Cells | 1 | 2013 | 9 | 0.020 |
Why?
|
| Chemokines | 1 | 2013 | 74 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 5525 | 0.020 |
Why?
|
| Transfection | 2 | 2002 | 319 | 0.020 |
Why?
|
| Receptors, Glucagon | 1 | 2010 | 1 | 0.020 |
Why?
|
| Cytophotometry | 1 | 2010 | 2 | 0.020 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2010 | 2 | 0.020 |
Why?
|
| Colforsin | 1 | 2010 | 12 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2010 | 150 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2013 | 667 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 194 | 0.020 |
Why?
|
| Calcium | 1 | 2010 | 243 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 633 | 0.020 |
Why?
|
| Papio ursinus | 1 | 2008 | 2 | 0.020 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2008 | 3 | 0.020 |
Why?
|
| Seroepidemiologic Studies | 1 | 2008 | 10 | 0.020 |
Why?
|
| Animals, Laboratory | 1 | 2008 | 7 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2008 | 48 | 0.020 |
Why?
|
| Polyomavirus Infections | 1 | 2008 | 7 | 0.020 |
Why?
|
| Models, Biological | 1 | 2010 | 468 | 0.020 |
Why?
|
| Rats | 1 | 2010 | 1587 | 0.020 |
Why?
|
| Subrenal Capsule Assay | 1 | 2004 | 5 | 0.010 |
Why?
|
| Exudates and Transudates | 1 | 2004 | 11 | 0.010 |
Why?
|
| Ganciclovir | 1 | 2004 | 7 | 0.010 |
Why?
|
| Abdominal Wall | 1 | 2004 | 9 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2004 | 60 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2004 | 90 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 154 | 0.010 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2003 | 4 | 0.010 |
Why?
|
| Thymidylate Synthase | 1 | 2003 | 7 | 0.010 |
Why?
|
| Sequence Homology | 1 | 2003 | 10 | 0.010 |
Why?
|
| Viral Load | 1 | 2003 | 32 | 0.010 |
Why?
|
| Herpes Simplex | 1 | 2002 | 20 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2002 | 160 | 0.010 |
Why?
|
| Virus Activation | 1 | 2001 | 9 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2001 | 39 | 0.010 |
Why?
|
| Antigens, Viral | 1 | 2001 | 24 | 0.010 |
Why?
|
| Plasmids | 1 | 2001 | 126 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2001 | 104 | 0.010 |
Why?
|